2018 has been a good year for Roche in financial terms certainly, but especially in bringing new medicines and diagnostics to patients. Severin Schwan talks about the tremendous demand for Roche’s recently launched product, which help patients suffering from breast and lung cancer, multiple sclerosis and haemophilia. He expresses confidence that Roche will continue to grow going forward despite the competition from biosimilars, the foundation of its success being and remaining its clear focus on innovation.
View the full 2018 annual report at [ Ссылка ]
Subscribe to our YouTube channel now: [ Ссылка ]
Get in touch with us:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
For more information and insights visit: [ Ссылка ]
